Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.

Related Articles
High hospital readmission rates plague the health care system.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the burden COPD places on society.
Leonard Nimoy’s recent death from end-stage chronic obstructive pulmonary disease (COPD) brought the condition into the spotlight, and may bring patients with questions to the pharmacy counter.
Latest Issues
$auto_registration$